TechConnect Innovation Program

Novel therapeutic for the treatment of ocular pathologies

LSU Health Sciences Center - New Orleans, Louisiana, United States

TECHNOLOGY SUMMARY

This technology is a treatment for corneal tissue pathology following viral infection, medical procedures, and accidental injury. Demonstrated by extensive testing in an in vivo rabbit eye system, the therapeutic has a strong anti-viral effect, is a potent anti-inflammatory agent, and has an anti-angiogenic effect while simultaneously promoting corneal healing.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Prototype

Technology Readiness Level: TRL 3

FIGURES OF MERIT

Value Proposition: Distinct advantages of this new therapeutic include reduced risk of secondary infections, a more rapid healing response, and no vision loss due to corneal clouding.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 737

Website: www.lsuhsc.edu

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: NIH P20RR021970
NIH P20GM103501

Primary Sources of Funding: Federal Grant, University

Looking for: Development / License Partners